Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Drug Design, Development and Therapy|November 19, 2009
Maraviroc in the treatment of HIV infectionNeelanjana RayJournal of Virology|March 16, 2004
Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesvirusesNeelanjana Ray, L W EnquistJournal of Virology|January 21, 2009
HR-2 mutations in human immunodeficiency virus type 1 gp41 restore fusion kinetics delayed by HR-1 mutations that cause clinical resistance to enfuvirtideNeelanjana Ray, Leslie A Blackburn, Robert W DomsJournal of Virology|November 16, 2004
Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virusNeelanjana Ray, Margaret E Bisher, L W EnquistJournal of Virological Methods|November 12, 2009
Study of Andes virus entry and neutralization using a pseudovirion systemNeelanjana Ray, Jillian Whidby, Shaun Stewart, et al.Antimicrobial Agents and Chemotherapy|June 19, 2013
Activity of the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitorsZhufang Li, Nannan Zhou, Yongnian Sun, et al.Antiviral Therapy|April 18, 2014
Changes in biomarkers in HIV-1-infected treatment-naive patients treated with tenofovir DF/emtricitabine plus atazanavir/ritonavir or lopinavir/ritonavir for 96 weeks: the CASTLE biomarker substudyGraeme Moyle, Helene Hardy, Jonathan Uy, et al.Journal of Virology|January 26, 2007
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitorsNeelanjana Ray, Jessamina E Harrison, Leslie A Blackburn, et al.Arthritis Research & Therapy|September 19, 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RAWilliam Rigby, Jane H Buckner, S Louis Bridges, et al.The British Journal of Ophthalmology|February 26, 2018
Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinomaPerumal Jayaraj, Seema Sen, Srishti Rangarajan, et al.Pageof 4